Overview
Marc Hirsh is a Hematologist Oncology provider in Hanover, Pennsylvania. Dr. Hirsh is highly rated in 23 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Paget Disease of the Breast.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Blue Cross Blue Shield
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. Marc A. Hirsh
Johns Hopkins University
Noah Hahn is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Hahn is highly rated in 16 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Orchiectomy. Dr. Hahn is currently accepting new patients.
Johns Hopkins University
Christine Hann is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Hann is highly rated in 16 conditions, according to our data. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma. Dr. Hann is currently accepting new patients.
Johns Hopkins University
Michael Streiff is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Streiff is highly rated in 61 conditions, according to our data. His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration. Dr. Streiff is currently accepting new patients.
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Lung Cancer
- Paget Disease of the Breast
- Pleuropulmonary Blastoma
- Small Cell Lung Cancer (SCLC)
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Anal Cancer
- Anemia
- Breast Cancer
- Cervical Cancer
- Chronic B-Cell Leukemia (CBCL)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Mountain Sickness
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)
- Adult Soft Tissue Sarcoma